相关实验视频
Updated: Jul 1, 2025

07:48
An Orthotopic Bladder Cancer Model for Gene Delivery Studies
Published on: December 1, 2013
12.5K
对膀癌中新辅助化疗的图书统计洞察:趋势,合作和未来的途径
Yi Huang1,2, Chengxiao Liao1,2, Zefeng Shen3
1Department of Urology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China.
Frontiers in immunology
|March 6, 2024
概括
这份关于膀癌新辅助化疗 (NAC) 的文献分析揭示了日益增长的研究趋势. 免疫化疗被确定为未来研究肌肉侵入性膀癌 (MIBC) 治疗的关键领域.
科学领域:
- 尿瘤学 尿瘤学
- 医学研究 医学研究
- 图书统计学 图书统计学
背景情况:
- 新辅助化疗 (NAC) 随后的激进囊切除术 (RC) 是肌肉侵入性膀癌 (MIBC) 的标准.
- 基于的NAC提供了好处,但对一些患者来说存在风险.
- 了解膀癌中NAC的研究趋势至关重要.
研究的目的:
- 分析关于膀癌新辅助化疗的文献.
- 确定研究轨迹和新兴领域.
- 为了提供该领域的文献统计概述.
主要方法:
- 科学网络核心集合 (1999-2022) 的系统文献搜索.
- 使用VOSviewer,CiteSpace和SCImago Graphica.使用的图书统计分析.
- 检查出版趋势,贡献,合作和关键词.
主要成果:
- 从1999年到2022年的1836个出版物显示了研究活动的增加.
- 美国在出版和合作方面处于领先地位;德克萨斯大学是顶级机构.
- 确定了关键作者,期刊和关键词,免疫化学疗法成为未来重要研究重点.
结论:
- 图书统计评估提供了NAC在膀癌研究中的全面观点.
- 该研究强调了当前的趋势和未来的研究方向.
- 免疫化学疗法对未来的膀癌治疗研究有显著的希望.
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K

